News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Karo Bio AB Release: Interim Report January-March 2014


5/8/2014 9:15:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The January–March period 2014 in brief

· Net sales amounted to MSEK 6.4 (8.1), first quarter last year included amortized upfront fees of MSEK 2,5
· Net loss for the group was MSEK 13.4 (10.7)
· Loss per share was SEK 0.03 (0.02)
· Cash flow from operating activities was MSEK -13.1 (-9.9)
· Cash and cash equivalents and other short-term investments totaled MSEK 8.6 (48.0) at the end of the period
· Financing of MSEK 1 granted by Vinnova for ERbeta cancer project

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES